Unité de Fabrication des Médicaments S.A Stock price

Equities

UMED

TN0007720014

Pharmaceuticals

End-of-day quote Tunis 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
7.27 TND +0.55% Intraday chart for Unité de Fabrication des Médicaments S.A -0.14% -2.81%
Sales 2023 * 134M 43.07M Sales 2024 * 141M 45.32M Capitalization 233M 74.77M
Net income 2023 * 16M 5.14M Net income 2024 * 18M 5.78M EV / Sales 2023 * 2.19 x
Net Debt 2023 * 61.1M 19.64M Net Debt 2024 * 66.6M 21.4M EV / Sales 2024 * 2.12 x
P/E ratio 2023 *
12.5 x
P/E ratio 2024 *
11.7 x
Employees 572
Yield 2023 *
6.88%
Yield 2024 *
7.57%
Free-Float 29.98%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.55%
1 week-0.14%
Current month+3.12%
1 month+3.86%
3 months-3.07%
6 months-5.58%
Current year-2.81%
More quotes
1 week
7.11
Extreme 7.11
7.27
1 month
7.04
Extreme 7.04
7.34
Current year
6.92
Extreme 6.92
7.56
1 year
6.85
Extreme 6.85
8.28
3 years
6.61
Extreme 6.61
8.65
5 years
6.61
Extreme 6.61
11.40
10 years
6.61
Extreme 6.61
11.40
More quotes
Managers TitleAgeSince
Chief Executive Officer - 88-12-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chief Executive Officer - 88-12-31
Director of Finance/CFO - -
Director/Board Member - 15-12-31
More insiders
Date Price Change Volume
24-03-28 7.27 +0.55% 7,412
24-03-27 7.23 0.00% 7,492
24-03-26 7.23 -0.55% 3,643
24-03-25 7.27 +0.41% 3,209
24-03-22 7.24 -0.55% 626

End-of-day quote Tunis, March 27, 2024

More quotes
Unimed (Unité de Fabrication de Médicaments) is one of the leading pharmaceutical groups in Tunisia. The activity is organized around 2 families of products: - generic medicines: primarily infusion and inhalation products, ophthalmic products, injectable liquids and powders; - fashioned medicines: medicines manufactured for third parties.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.27 TND
Average target price
11.2 TND
Spread / Average Target
+54.06%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Unité de Fabrication des Médicaments S.A - Tunis